Showing posts with label 000 lives a year. Show all posts
Showing posts with label 000 lives a year. Show all posts

Monday, January 12, 2015

Patients to be allowed to refer themselves for cancer tests: Family doctors will also be able to send a person straight for scans in effort to save 8,000 lives a year

  • More than 60 hospitals to run pilot scheme to improve cancer survival rate
  • NHS said increasing number of tumours caught early will save many lives
  • David Cameron insists Britain ‘must never rest’ in fight to beat cancer




  • People who fear they have cancer will be able to bypass their GP and refer themselves for tests, in an effort to save an extra 8,000 lives a year.
    Other plans for speeding up diagnosis include lowering the bar for referrals and allowing family doctors to send patients straight for scans without them seeing a consultant first.
    More than 60 hospitals in England will run pilot schemes aimed at improving cancer survival rates by catching the disease earlier.
    Speeding up diagnosis: People who fear they have cancer will be able to bypass their GP and refer themselves for tests, in an effort to save an extra 8,000 lives a year
    Speeding up diagnosis: People who fear they have cancer will be able to bypass their GP and refer themselves for tests, in an effort to save an extra 8,000 lives a year
    NHS England says that increasing the number of tumours caught early by even 10 per cent would save 8,000 lives a year.
    Better diagnosis would also reduce pressure on A&E units, which currently spot up to a quarter of cases of the disease.
    David Cameron said Britain ‘must never rest’ in its determination to beat cancer. Half of all cases are spotted at a late stage, when treatment is less likely to be successful, and survival rates are among the worst in Europe.



    A new NHS cancer taskforce will evaluate seven schemes designed to speed up diagnosis, including self-referral for tests.
    The proposal has been welcomed by radiologists, whose scans and X-rays are the first line of diagnosis for most cancers.
    But they said any increase in testing must be matched with investment in staff. Lack of resources means many patients wait more than a month for the results of potentially vital X-rays, CT and MRI scans.
    Giles Maskell, president of the Royal College of Radiologists, said early testing was key to saving lives, but added: ‘We are already seeing the system creaking at the seams. We definitely welcome the focus on early diagnosis but it has to come with investment.’
    More than 60 hospitals in England will run pilot schemes aimed at improving cancer survival rates by catching the disease earlier
    More than 60 hospitals in England will run pilot schemes aimed at improving cancer survival rates by catching the disease earlier
    It is unlikely that those who self-refer will get direct access to tests, Dr Maskell said. Instead, it may be that those who are worried will go to a special clinic to be assessed.
    Other ideas to be covered by pilot schemes include making it easier for patients to have multiple tests in the same place on the same day and encouraging pharmacists to refer repeat customers for tests.
    The shake-up of cancer services also includes extra funding for a very precise form of radiotherapy that can be used to kill tumours which surgeons dare not cut out. Stereotactic ablative radiotherapy, or Cyberknife, has been championed by former England rugby captain Lawrence Dallaglio, whose mother died from cancer.
    He said the £15million funding boost over three years will double the number of patients who can benefit from the treatment.
    NHS England chief Simon Stevens said ‘too many patients are still being diagnosed late … so it’s time for a fresh look at how we can do even better’.
    Cancer Research UK’s Harpal Kumar, head of the taskforce, said the charity predicts cases will increase by a third over the next 15 years, ‘so the time is right to set new ambitions and look at how we will meet this need’.
    • The Cancer Drugs Fund is unethical and should be scrapped, the National Health Action Party claims. Co-leader Dr Clive Peedell said extra money for cancer drugs ‘undermines the fundamental NHS principle that all patients should be treated equally’.


    Read more: http://www.dailymail.co.uk/health/article-2905964/Patients-allowed-refer-cancer-tests-Family-doctors-able-send-person-straight-scans-effort-save-8-000-lives-year.html#ixzz3OcYDeke3 
    Follow us: @MailOnline on Twitter | DailyMail on Facebook
     
     

    Thursday, January 10, 2013

    Single smear test could detect three types of cancer in women which claim 7,000 lives a year

  • WWW.HEALTHYBARN.COM
  • New test can detect cancer of the cervix, womb and ovaries
  • During trials, it found 40% of ovarian tumours - known as 'the silent killer'
  • Method had a 100% success rate in detecting endometrial cancer

  •  

    The three cancer test is being developed by researchers at John Hopkins Kimmel Cancer Center in Baltimore, Maryland
    Breakthrough: The test - based on the existing smear test to detect cervical cancer - can also find ovarian and endometrial cancers (stock image)
    A major breakthrough in the battle against female cancer was signalled last night with the emergence of a single test to detect three different types of the disease.
    Based on the existing smear test for cancer of the cervix, it also checks for the disease in the ovaries and the womb.
    The test is under development by scientists in the US and is expected to be simple and relatively cheap.
    Helping to detecting ovarian cancer – dubbed ‘the silent killer’ – would be a significant breakthrough. 
    It exhibits no symptoms in its early stages and is usually not diagnosed until it is too late, proving fatal in two-thirds of cases.
    Cancer of the lining of the womb, known as endometrial cancer, is easier to spot but still claims 1,400 lives annually.
    The new research builds on the success of the smear test, which looks for abnormalities in cells in the cervix, the entrance to the womb. 
    The five-minute procedure is routinely offered every three years to women aged 25 to 49 and then every five years up to 65. The test is credited with cutting the number of cases of cervical cancer by three-quarters since it was introduced.

     

    However, until now there has been no reliable way of screening for ovarian and endometrial cancers.
    The researchers, from Johns Hopkins Kimmel Cancer Center in Baltimore, Maryland, identified abnormal genes found in specific types of cancerous cells. 
    A new method: The three cancer test is being developed by researchers at John Hopkins Kimmel Cancer Center in Baltimore, Maryland, pictured
    A new method: The three cancer test is being developed by researchers at John Hopkins Kimmel Cancer Center in Baltimore, Maryland, pictured
    They then examined cervical smear test samples, looking for cancerous cells from the ovaries or the womb that had broken off and made their way to the cervix.
    This method had a 100 per cent success rate in detecting endometrial cancer. It also found 40 per cent of ovarian tumours.
    Cancers were detected in both the early and late stages.
    Triple threat
    In addition, no women who were in fact healthy were falsely diagnosed as having cancer. The success rate for ovarian cancer may seem low, but the test may still detect cases that would not otherwise be spotted until too late.
    Writing in the journal Science Translational Medicine, the researchers said testing for more genes might give a better result.
    More research including large-scale trials is needed before the PapGene test, as it is known, is ready for the market. It will be at least a decade before it is widely available. Researcher Dr Shannon Westin, of the University of Texas, said that in order to catch all three cancers, smear tests might have to be given throughout life, rather than just until the age of 65.
    Hazel Nunn of Cancer Research UK welcomed news of the test, saying: ‘Looking for evidence of ovarian and womb cancer in women’s smear test samples is a clever idea.Such promising results warrant research on a larger scale to see if this approach could pick up these diseases in the early stages when the chances of survival are best.’ 
    Gilda Witte, chief executive of Ovarian Cancer Action, said: ‘This is very promising news indeed.’
    But she added a note of caution that the research is in its early stages and women need to be aware of ovarian cancer symptoms so it is diagnosed as early as possible. 
    The main symptoms are persistent stomach pain and bloating, difficulty eating or feeling full quickly and the need to urinate more often.


    Read more: http://www.dailymail.co.uk/health/article-2259760/Single-test-detect-types-cancer-women-claim-7-000-lives-year.html#ixzz2HazULzLX 
    Follow us: @MailOnline on Twitter | DailyMail on Facebook